menu
    • menu

    Company profile for Transcenta Holding

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a group of people with passion and experience for developing innovative medicines to serve patients around the world. We operate globally and focus on biologics, and we have established a fully integrated capability with a Discovery, Clinical and Translational Research Center in Suzhou, a Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Shanghai, Beijing ...
    We are a group of people with passion and experience for developing innovative medicines to serve patients around the world. We operate globally and focus on biologics, and we have established a fully integrated capability with a Discovery, Clinical and Translational Research Center in Suzhou, a Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Shanghai, Beijing and Princeton, US, and an External Partnering Center in Boston, US.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Transcenta HoldingChina Flag
    Country
    Country
    China
    Address
    Address
    218 Xinghu Street, Biobay B6-501, Suzhou
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.transcenta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/transcenta
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Transcenta, EirGenix Partner To Revolutionize Biologics
    Transcenta, EirGenix Partner To Revolutionize Biologics

    31 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/transcenta-teams-up-with-eirgenix-to-revolutionise-biologics-manufacturing-18732

    INDPHARMAPOST
    31 Dec 2025
    Share Share
    Transcenta Therapeutics Inks Collaboration Pact
    Transcenta Therapeutics Inks Collaboration Pact

    28 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210760/0/en/Transcenta-Therapeutics-Announces-Strategic-Collaboration-and-Non-exclusive-Licensing-Agreement-to-Advance-Integrated-Continuous-Biomanufacturing-and-Expand-Global-Access-to-Afford.html

    GLOBENEWSWIRE
    28 Dec 2025
    Share Share
    Transcenta Highlights LIV-1 ADC Efficacy In TNBC Tumor At SABCS
    Transcenta Highlights LIV-1 ADC Efficacy In TNBC Tumor At SABCS

    12 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-debuts-promising-anti-tumor-activity-of-novel-liv-1-targeting-adcs-with-site-specific-conjugated-topo-i-inhibitor-payload-in-tnbc-tumor-models-at-2024-sabcs-302330235.html

    PR NEWSWIRE
    12 Dec 2024
    Share Share
    Transcenta Shows Efficacy of Osemitamab in G/GEJ Cancer at ESMO 2024
    Transcenta Shows Efficacy of Osemitamab in G/GEJ Cancer at ESMO 2024

    18 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-updates-encouraging-efficacy-data-from-first-line-triple-combo-trial-of-osemitamab-tst001-for-ggej-cancer-at-esmo-2024-302251645.html

    PR NEWSWIRE
    18 Sep 2024
    Share Share
    Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results
    Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results

    29 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/transcenta-holding-limited-stock-code-6628hk-announce-2024-interim-results-302233808.html

    PR NEWSWIRE
    29 Aug 2024
    Share Share
    Transcenta collaborates Agilent to develop Claudin18.2 to support Osemitamab
    Transcenta collaborates Agilent to develop Claudin18.2 to support Osemitamab

    09 Apr 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=168441&sid=2

    PHARMABIZ
    09 Apr 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search